{"transactions":[{"id":815927,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T21:27:51.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will fully vest on March 23, 2029, the three-year anniversary of the grant, subject to the Reporting Person's continued service through to that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will fully vest on March 23, 2029, the three-year anniversary of the grant, subject to the Reporting Person's continued service through to that date."}],"balance_after":100000,"derivative":{"exercise_date":"2029-03-23","expiration_date":"2029-03-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-26-011291","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774926011291/rdgdoc.xml","form_type":"4"}},{"id":1036181,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Incentive stock options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036180,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":61534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":61534},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036179,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":61534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036178,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":81534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036177,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":4,"value":400000.0,"ownership":{"direct":true},"balance_after":284406,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036176,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":61534,"price":4,"value":246136.0,"ownership":{"direct":true},"balance_after":184406,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036175,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":16.21,"value":324200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.00 to $16.44 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036174,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-17","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":4,"value":80000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":142872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036173,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":16.28,"value":407000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.49 to $16.78 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1036172,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-19T00:44:13.000Z","date":"2025-09-16","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029432","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029432/rdgdoc.xml","form_type":"4"}},{"id":1040221,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":106534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040220,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":131534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040219,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015."}],"balance_after":156534,"derivative":{"exercise_price":4,"exercise_date":"2019-09-08","expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040218,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":15.77,"value":394250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040217,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040216,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":14.32,"value":358000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040215,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040214,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":14.78,"value":369500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1040213,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-09-16T01:09:38.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."}],"balance_after":147872,"source":{"system":"sec-edgar","filing":"0001437749-25-029104","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925029104/rdgdoc.xml","form_type":"4"}},{"id":1109569,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-06-17T00:23:49.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":15.98,"value":239700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.90 to $16.04 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001437749-25-020563","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925020563/rdgdoc.xml","form_type":"4"}},{"id":1109568,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-06-17T00:23:49.000Z","date":"2025-06-12","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":16.4,"value":246000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.32 to $16.57 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":137872,"source":{"system":"sec-edgar","filing":"0001437749-25-020563","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774925020563/rdgdoc.xml","form_type":"4"}},{"id":1749490,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T21:36:40.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control."}],"balance_after":330000,"derivative":{"exercise_price":4.38,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001437749-23-030248","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923030248/rdgdoc.xml","form_type":"4"}},{"id":1829468,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-15T00:27:44.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 12, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to two tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $4 billion, in both cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":200000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-07-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-23-019991","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923019991/rdgdoc.xml","form_type":"4"}},{"id":1833580,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Warrant (right to buy)","published_at":"2023-07-07T00:36:07.000Z","date":"2023-06-12","kind":"other","planned":false,"acquired":false,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001437749-23-019539","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923019539/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-06-13"}},{"id":1833579,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-07-07T00:36:07.000Z","date":"2023-06-12","kind":"other","planned":false,"acquired":true,"shares":7365,"price":2.05,"value":15098.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person."}],"balance_after":148941,"source":{"system":"sec-edgar","filing":"0001437749-23-019539","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923019539/rdgdoc.xml","form_type":"4/A","original_submission_date":"2023-06-13"}},{"id":1857005,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Warrant (right to buy)","published_at":"2023-06-13T21:25:39.000Z","date":"2023-06-12","kind":"other","planned":false,"acquired":false,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001437749-23-017295","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923017295/rdgdoc.xml","form_type":"4"}},{"id":1857004,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-06-13T21:25:39.000Z","date":"2023-06-12","kind":"other","planned":false,"acquired":true,"shares":7365,"price":2.05,"value":15098.25,"ownership":{"direct":true},"balance_after":877636,"source":{"system":"sec-edgar","filing":"0001437749-23-017295","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923017295/rdgdoc.xml","form_type":"4"}},{"id":1908036,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-03T01:45:19.000Z","date":"2023-04-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 29, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":500000,"derivative":{"exercise_price":6.44,"expiration_date":"2033-04-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001437749-23-012179","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000143774923012179/rdgdoc.xml","form_type":"4"}},{"id":2235631,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-06-10T22:57:53.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":7365,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":7365,"derivative":{"exercise_price":2.05,"exercise_date":"2022-06-09","expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001387131-22-006921","document":"uecker-form4_060922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000138713122006921/uecker-form4_060922.xml","form_type":"4"}},{"id":2235630,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T22:57:53.000Z","date":"2022-06-09","kind":"other","acquired":true,"shares":7365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05."}],"balance_after":137376,"source":{"system":"sec-edgar","filing":"0001387131-22-006921","document":"uecker-form4_060922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000138713122006921/uecker-form4_060922.xml","form_type":"4"}},{"id":2772977,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-24T22:15:45.000Z","date":"2021-03-22","kind":"grant","acquired":true,"shares":54750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":54750,"derivative":{"exercise_price":24.03,"exercise_date":"2022-03-01","expiration_date":"2031-03-22","underlying":"Common Stock","underlying_shares":54750},"source":{"system":"sec-edgar","filing":"0001209191-21-022926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919121022926/doc4.xml","form_type":"4"}},{"id":2772976,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-24T22:15:45.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020."}],"balance_after":37500,"derivative":{"exercise_price":10.66,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-21-022926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919121022926/doc4.xml","form_type":"4"}},{"id":2894945,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2021-01-26T21:12:54.000Z","date":"2021-01-25","kind":"other","acquired":false,"shares":1284,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":1284},"source":{"system":"sec-edgar","filing":"0001209191-21-005359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919121005359/doc4.xml","form_type":"4"}},{"id":2894944,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-26T21:12:54.000Z","date":"2021-01-25","kind":"other","acquired":true,"shares":1284,"price":7.01,"value":9000.84,"ownership":{"direct":true},"balance_after":127893,"source":{"system":"sec-edgar","filing":"0001209191-21-005359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919121005359/doc4.xml","form_type":"4"}},{"id":3106632,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Warrant (right to buy)","published_at":"2020-06-17T20:07:38.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":1284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":1284,"derivative":{"exercise_price":7.01,"exercise_date":"2020-06-15","expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":1284},"source":{"system":"sec-edgar","filing":"0001209191-20-037230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919120037230/doc4.xml","form_type":"4"}},{"id":3106631,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-06-17T20:07:38.000Z","date":"2020-06-15","kind":"other","acquired":true,"shares":8563,"price":7.01,"value":60026.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares and warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering, as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."}],"balance_after":126609,"source":{"system":"sec-edgar","filing":"0001209191-20-037230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919120037230/doc4.xml","form_type":"4"}},{"id":3500265,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-06-06T01:31:34.000Z","date":"2019-06-03","kind":"tax_withholding","acquired":false,"shares":36321,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Uecker's June 2017 Restricted Stock Unit grant agreement (\"RSU agreement\") previously disclosed and filed on Form 8-K.  Mr. Uecker has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The market close price of $11.51 per share on June 3, 2019 was used to calculate the number of withheld shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":118046,"source":{"system":"sec-edgar","filing":"0001209191-19-034965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919119034965/doc4.xml","form_type":"4"}},{"id":3907937,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2018-06-04T21:59:44.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":7168,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Uecker's June 2017 RSU grant agreement previously disclosed and filed on Form 8-K.  Mr. Uecker has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The market close price of $16.10 per share on June 1, 2018 was used to calculate the number of withheld shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":153981,"source":{"system":"sec-edgar","filing":"0001209191-18-035292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919118035292/doc4.xml","form_type":"4"}},{"id":4286775,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T20:07:30.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":195000,"derivative":{"exercise_price":30.99,"exercise_date":"2017-06-07","expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001209191-17-038858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919117038858/doc4.xml","form_type":"4"}},{"id":4286774,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T20:07:30.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":187286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over a four year period that began on June 21, 2016, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":187286,"derivative":{"exercise_price":30.99,"exercise_date":"2017-06-07","expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":187286},"source":{"system":"sec-edgar","filing":"0001209191-17-038858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919117038858/doc4.xml","form_type":"4"}},{"id":4286773,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":53799,"kind":"person","name":"UECKER DARRIN","position":1,"cik":"0001276311","reported_name":"UECKER DARRIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2017-06-09T20:07:30.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":160974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will fully vest on June 1, 2018, subject to the Reporting Person's continued service as of that date."}],"balance_after":160974,"source":{"system":"sec-edgar","filing":"0001209191-17-038858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276311/000120919117038858/doc4.xml","form_type":"4"}}]}